Keywords: strong, data, merck, serono, phenoptin, says, its

Strong data on Merck Serono's Phenoptin

Article | 22 January 2007

Merck Serono says that its drug candidate for phenylketonuria, Phenoptin (sapropterin dihydrochloride), caused a significant increase in phenylalanine tolerance as ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Merck

Merck KGaA

Go to company listing